[Treatment of acute pyoinflammatory diseases of the lungs and pleura under control of microorganism persistence factors].
Results of treatment of patients with acute pulmonary abscess, acute empyema of the pleura and pyopneumothorax were analyzed. The local treatment of the main group of patients consisting of 50 persons included oxitocin in combination with antiseptics and antibiotics which facilitated maximal reduction of the persistent potential of the pathogenic agent, its rapid elimination from the purulent focus and allowed to get better results using conservative therapy. The obtained clinical effect confirmed the experimental data on pronounced inhibition of persistent properties of the bacterial pathogens with the complexes "antibiotic-oxitocin".
Abramzon
O M
OM
Bukharin
O V
OV
Kurlaev
P P
PP
D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D002437:Cefazolin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D016724:Empyema, Pleural / Q000188:drug therapy* / Q000382:microbiology*; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009583:Nitrofurazone / Q000627:therapeutic use; D010462:Peptostreptococcus / Q000302:isolation & purification; D011030:Pneumothorax / Q000188:drug therapy* / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D002437:Cefazolin; D009583:Nitrofurazone